Gestione degli effetti collaterali piu comuni dovuti alla somministrazione di amfotericina B

Amphotericin B represents one of the most important drugs available for antifungal therapy especially in the compromised patient. Unfortunately its administration presents many infusion-related or infusion-unrelated adverse effects, which are less frequent (but not absent) in patients receiving lipid-based formulations of amphotericin B. The present paper represents a summary of the prophylactic and therapeutic options available to manage amphotericin B related adverse events.